ArticleMolecular therapy. Methods & clinical development2021

AAV9-mediated gene delivery of MCT1 to oligodendrocytes does not provide a therapeutic benefit in a mouse model of ALS.

Caroline Eykens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.